Healthy Male and Female SubjectsPhase 1NCT06974227
Validation Study of an Assistive Pulse Data Collection Device
A Phase 1 study testing Assistive Pulse Data Collection (APDC) Device in people with Healthy Male and Female Subjects, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
Trial summary
Background: Traditional Chinese Medicine (TCM) relies on pulse diagnosis, a subjective and complex method that is crucial for assessing patients' health status. The COVID-19 pandemic has disrupted healthcare delivery, highlighting the need for remote diagnostic tools. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy Male and Female Subjects
- What is being tested?
- Assistive Pulse Data Collection (APDC) Device
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Mar 2025to 31 Jul 2025
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18-65 years
- BMI 18.5-22.5 kg/m2
- Willing to give informed consent
Who cannot join
- 1. dorsally located radial artery
Trial locations and contacts
1 site in 1 country.
About this study
Background: Traditional Chinese Medicine (TCM) relies on pulse diagnosis, a subjective and complex method that is crucial for assessing patients' health status. The COVID-19 pandemic has disrupted healthcare delivery, highlighting the need for remote diagnostic tools. To address this, an Assistive Pulse Data Collection Device (APDC) has been developed to capture and regenerate pulse features for remote pulse assessment in TCM.
Objective: This study aims to validate the accuracy and reliability of the APDC by assessing its agreement with Chinese Medicine Practitioners (CMPs) and collecting users' feedback.
Read more
Intervention: The APDC consists of a radial artery viewing device, pulse collection device, and pulse regeneration device.
Methods: Subjects will be recruited via social media and posters at the University. Inclusion criteria include age 18-65 years and BMI 18.5-22.5 kg/m2, while exclusion criteria include a dorsally located radial artery. Registered CMPs with at least 5 years of clinical experience will assess the pulse from both participants and the regenerated pulse by the device.
Outcome Assessment: Agreement in pulse features between the subjects' real pulse and the pulse regeneration device will be assessed using a self-developed questionnaire, covering frequency, rhythm, wideness, and force. Quantitative and qualitative feedback from subjects and CMPs will be collected to assess their views on the APDC Device in terms of satisfaction, ease of use, and comfortability.
Read the detailed description
This study aims to assess whether the CMP can correctly recognize the pulse feature generated from the APDC Device and match it with the subjects. Its purpose is to ensure that the device-regenerated pulse resembles the subjects' pulse.
Feasibility Phase During the Feasibility Phase, users' experience from both CMPs and subjects will be collected for the team to refine the setting of the APDC Device.
Procedure
- A subject's pulse features will be recorded by the APDC Device;
- Three CMPs will assess the subject's pulse of both hands and then the regeneration pulse from the APDC Device;
- The CMPs will rate the agreement, using a predefined record form (appendix 1), on the likeliness between the subjects' pulse and PTSE-regenerated pulse, in the respects of frequency, rhythm, wideness, and force (5-point Likert for each domain, from "Strongly disagree" to "strongly agree")
- Subjects' user experience will be assessed by a questionnaire (appendix 2);
- The above steps repeat until 10 subjects' pulses have been assessed.
The engineer team will then adjust and improve the machine based on the user feedback.
Pilot Phase In the Pilot Phase, the above procedure will be repeated until 12 CMPs' and 35 subjects' feedback have been collected.
Blinding the practitioners is not feasible due to the inherent differences between the simulator and a real subject. In this case, the study design focuses on the practitioners' ability to match the pulse features from the simulator to those of the patients using categorical responses.
Procedure
- Three CMPs will take turns to assess five subjects' pulses;
- The CMPs will categorize each subject's pulse, in the respects of frequency, rhythm, wideness, and force at three places of the wrist, which are known as cun, guan, and chi;
- The CMPs will then assess the five regenerated pulses from the APDC Device in random order. They will be informed that the pulses are generated from the five subjects they have just assessed in random order;
- The CMPs will categorize and the APDC-regenerated pulse, using the same approach; they will be asked to match the PTSE-regenerated pulse with the subjects.
- The above procedure will repeat until thirty subjects are assessed.
Subject recruitment Subjects will be recruited via social media and posters at the University. All subjects will be required to sign a consent form indicating their voluntary participation. Their socio-demographic characteristics will be recruited. The Pulse Taking System Device will digitalize the pulse feature in waveform data. Registered CMPs with at least 5 years of clinical experience will be recruited to assess the pulse from both participants and the device; afterward, they will fill out a predefined record form to rate the pulse characteristics. A HK$100 supermarket coupon will be given to the subject as an incentive upon completion of either phase 1 or 2.
Subjects
- Inclusion criteria
- Age 18-65 years
- BMI 18.5-22.5 kg/m2
- Willing to give informed consent
- Exclusion criteria 1. dorsally located radial artery
Pulse taking setting The CMPs will assess the subjects' pulse as if they were in clinical practice. Subjects will sit on a chair, put their arm on a table, and position their wrist on a pulse pillow. The CMP will assess the subjects' pulse for up to one minute each.
Outcome assessment Agreement in pulse feature between the CMPs and the pulse regeneration device will be assessed using a self-developed questionnaire. The questionnaire will cover the pulse features including frequency, rhythm, wideness, and force.
Users' experience As the APDC Device consists of three parts, namely artery viewing device, pulse collection device, and pulse re-generation device. Device will be assessed separately.
Quantitative feedback from the subjects and CMPs will be collected via a self-developed questionnaire using 5-point Likert items to assess their view on the Pulse Taking System Device, in terms of the satisfaction, ease to use, and comfortability etc.
Qualitative feedback from the subjects and CMPs will be collected using open end questions by a self-completed questionnaire. The ease of use and further suggestions for the pulse taking system device will be collected.
- Conditions
- Healthy Male and Female Subjects
- Being tested
- Assistive Pulse Data Collection (APDC) Device
- Keywords
- machine, pulse, wave form, TCM
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Assistive Pulse Data Collection (APDC) DeviceDevice
An Assistive Pulse Data Collection Device prototype has been designed and manufactured by the Logistics and Supply Chain MultiTech R\&D Centre, Hong Kong. The device comprises a pulse sensor to record the patient's pulse and digitalize the pulse feature into waveform data. The digitalized waveform data is then converted the electronic signal into mechanical vibration that responds to the patient's pulse.
| Study group | Role | What they receive |
|---|---|---|
| Assistive Pulse Data Collection (APDC) Device | Experimental | An Assistive Pulse Data Collection Device prototype has been designed and manufactured by the Logistics and Supply Chain MultiTech R\&D Centre, Hong Kong. The device comprises a pulse sensor to record the patient's pulse and digitalize the pulse feature into waveform data. The digitalized waveform data is then converted the electronic signal into mechanical vibration that responds to the patient's pulse. Receives: Device: Assistive Pulse Data Collection (APDC) Device |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rating on the Agreement in pulse feature
CMPs will rate their level of agreement with statements regarding the similarity between the machine-generated pulse and the actual pulse of subjects. Responses will be recorded using a 5-point Likert scale, ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The questionnaire (4-item) evaluated four key pulse attributes: frequency, rhythm, wideness, and force.
CMPs will assess the extent to which they agreed that the frequency of the machine-regenerated pulse accurately resembled that of a real person's pulse. Similarly, they evaluated the rhythm, wideness, and force of the machine-generated pulse in comparison to the actual pulse.
Measured: Baseline
Secondary outcomes (1)
Subjects feedback on the device
Subjects' feedback on their experience with the pulse measurement process was collected. Subjects will indicate their level of agreement with various statements using a 5-point scale (1 "Not at all" to 5 "Very Much"). The questionnaire is 4-item, each focused on four key areas: comfort during the measurement process, ease of understanding and using the machine, the efficiency of the measurement process, and overall satisfaction with the experience. It aims to assess the user-friendliness and effectiveness of the machine from the subjects ' perspective.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2025
- Study start1 Mar 2025
- Primary completion30 Jun 2025
- Study completion31 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Healthy Male and Female SubjectsStudies of the same condition, open and under way.
- More trials run by The Hong Kong Polytechnic UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- The Hong Kong Polytechnic University
- Sponsor type
- University, hospital or other
- Collaborators
- Logistics and Supply Chain MultiTech R&D Centre, Hong Kong
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06974227
- Sponsor's protocol ID
- PRM
- Status last verified
- Mar 2025
- First submitted
- 9 Mar 2025
- Last updated
- 24 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The IP will be owned by the other company.
Publications
Ruan JY, Chen S, Wu M, Li S, Ho YS, Fan KL, Chow WL, Chiu L, Yeung WF. Assistive Technologies for Pulse-Based Tele-Practice in Traditional Chinese Medicine: Two-Phase, Dual-Method Feasibility and Pilot Study. JMIR Hum Factors. 2026 Mar 6;13:e77740. doi: 10.2196/77740.
PubMed 41813224
Study at a glance
From the registry record, last updated by the sponsor on 24 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation Study of an Assistive Pulse Data Collection Device
- ClinicalTrials.gov ID
- NCT06974227
- Acronym / sponsor ID
- PRM
- Conditions
- Healthy Male and Female Subjects
- Keywords
- machine, pulse, wave form, TCM
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- The Hong Kong Polytechnic UniversityUniversity, hospital or other
- Collaborators
- Logistics and Supply Chain MultiTech R&D Centre, Hong Kong
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 30 Jun 2025 (actual)
- Study completion
- 31 Jul 2025 (actual)
- First posted
- 15 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Traditional Chinese Medicine (TCM) relies on pulse diagnosis, a subjective and complex method that is crucial for assessing patients' health status. The COVID-19 pandemic has disrupted healthcare delivery, highlighting the need for remote diagnostic tools. To address this, an Assistive Pulse Data Collection Device (APDC) has been developed to capture and regenerate pulse features for remote pulse assessment in TCM.
Objective: This study aims to validate the accuracy and reliability of the APDC by assessing its agreement with Chinese Medicine Practitioners (CMPs) and collecting users' feedback.
Intervention: The APDC consists of a radial artery viewing device, pulse collection device, and pulse regeneration device.
Methods: Subjects will be recruited via social media and posters at the University. Inclusion criteria include age 18-65 years and BMI 18.5-22.5 kg/m2, while exclusion criteria include a dorsally located radial artery. Registered CMPs with at least 5 years of clinical experience will assess the pulse from both participants and the regenerated pulse by the device.
Outcome Assessment: Agreement in pulse features between the subjects' real pulse and the pulse regeneration device will be assessed using a self-developed questionnaire, covering frequency, rhythm, wideness, and force. Quantitative and qualitative feedback from subjects and CMPs will be collected to assess their views on the APDC Device in terms of satisfaction, ease of use, and comfortability.
Detailed description
This study aims to assess whether the CMP can correctly recognize the pulse feature generated from the APDC Device and match it with the subjects. Its purpose is to ensure that the device-regenerated pulse resembles the subjects' pulse.
Feasibility Phase During the Feasibility Phase, users' experience from both CMPs and subjects will be collected for the team to refine the setting of the APDC Device.
Procedure
- A subject's pulse features will be recorded by the APDC Device;
- Three CMPs will assess the subject's pulse of both hands and then the regeneration pulse from the APDC Device;
- The CMPs will rate the agreement, using a predefined record form (appendix 1), on the likeliness between the subjects' pulse and PTSE-regenerated pulse, in the respects of frequency, rhythm, wideness, and force (5-point Likert for each domain, from "Strongly disagree" to "strongly agree")
- Subjects' user experience will be assessed by a questionnaire (appendix 2);
- The above steps repeat until 10 subjects' pulses have been assessed.
The engineer team will then adjust and improve the machine based on the user feedback.
Pilot Phase In the Pilot Phase, the above procedure will be repeated until 12 CMPs' and 35 subjects' feedback have been collected.
Blinding the practitioners is not feasible due to the inherent differences between the simulator and a real subject. In this case, the study design focuses on the practitioners' ability to match the pulse features from the simulator to those of the patients using categorical responses.
Procedure
- Three CMPs will take turns to assess five subjects' pulses;
- The CMPs will categorize each subject's pulse, in the respects of frequency, rhythm, wideness, and force at three places of the wrist, which are known as cun, guan, and chi;
- The CMPs will then assess the five regenerated pulses from the APDC Device in random order. They will be informed that the pulses are generated from the five subjects they have just assessed in random order;
- The CMPs will categorize and the APDC-regenerated pulse, using the same approach; they will be asked to match the PTSE-regenerated pulse with the subjects.
- The above procedure will repeat until thirty subjects are assessed.
Subject recruitment Subjects will be recruited via social media and posters at the University. All subjects will be required to sign a consent form indicating their voluntary participation. Their socio-demographic characteristics will be recruited. The Pulse Taking System Device will digitalize the pulse feature in waveform data. Registered CMPs with at least 5 years of clinical experience will be recruited to assess the pulse from both participants and the device; afterward, they will fill out a predefined record form to rate the pulse characteristics. A HK$100 supermarket coupon will be given to the subject as an incentive upon completion of either phase 1 or 2.
Subjects
- Inclusion criteria
- Age 18-65 years
- BMI 18.5-22.5 kg/m2
- Willing to give informed consent
- Exclusion criteria 1. dorsally located radial artery
Pulse taking setting The CMPs will assess the subjects' pulse as if they were in clinical practice. Subjects will sit on a chair, put their arm on a table, and position their wrist on a pulse pillow. The CMP will assess the subjects' pulse for up to one minute each.
Outcome assessment Agreement in pulse feature between the CMPs and the pulse regeneration device will be assessed using a self-developed questionnaire. The questionnaire will cover the pulse features including frequency, rhythm, wideness, and force.
Users' experience As the APDC Device consists of three parts, namely artery viewing device, pulse collection device, and pulse re-generation device. Device will be assessed separately.
Quantitative feedback from the subjects and CMPs will be collected via a self-developed questionnaire using 5-point Likert items to assess their view on the Pulse Taking System Device, in terms of the satisfaction, ease to use, and comfortability etc.
Qualitative feedback from the subjects and CMPs will be collected using open end questions by a self-completed questionnaire. The ease of use and further suggestions for the pulse taking system device will be collected.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Assistive Pulse Data Collection (APDC) Device | Experimental | Device: Assistive Pulse Data Collection (APDC) DeviceAn Assistive Pulse Data Collection Device prototype has been designed and manufactured by the Logistics and Supply Chain MultiTech R\&D Centre, Hong Kong. The device comprises a pulse sensor to record the patient's pulse and digitalize the pulse feature into waveform data. The digitalized waveform data is then converted the electronic signal into mechanical vibration that responds to the patient's pulse. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age 18-65 years
- BMI 18.5-22.5 kg/m2
- Willing to give informed consent
Key exclusion criteria (1 listed)
- 1. dorsally located radial artery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Assistive Pulse Data Collection (APDC) DeviceAn Assistive Pulse Data Collection Device prototype has been designed and manufactured by the Logistics and Supply Chain MultiTech R\&D Centre, Hong Kong. The device comprises a pulse sensor to record the patient's pulse and digitalize the pulse feature into waveform data. The digitalized waveform data is then converted the electronic signal into mechanical vibration that responds to the patient's pulse. | Device | Assistive Pulse Data Collection (APDC) Device |
Primary outcome
Rating on the Agreement in pulse feature
Time frame: Baseline
CMPs will rate their level of agreement with statements regarding the similarity between the machine-generated pulse and the actual pulse of subjects. Responses will be recorded using a 5-point Likert scale, ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The questionnaire (4-item) evaluated four key pulse attributes: frequency, rhythm, wideness, and force. CMPs will assess the extent to which they agreed that the frequency of the machine-regenerated pulse accurately resembled that of a real person's pulse. Similarly, they evaluated the rhythm, wideness, and force of the machine-generated pulse in comparison to the actual pulse.
1 secondary outcome
Subjects feedback on the device
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Sep 2026.
- Derived from this study: PubMed 41813224Ruan JY, Chen S, Wu M, Li S, Ho YS, Fan KL, Chow WL, Chiu L, Yeung WF. Assistive Technologies for Pulse-Based Tele-Practice in Traditional Chinese Medicine: Two-Phase, Dual-Method Feasibility and Pilot Study. JMIR Hum Factors. 2026 Mar 6;13:e77740. doi: 10.2196/77740.
- Individual participant dataSharing planned: No. The IP will be owned by the other company.
Related trials for Healthy Male and Female Subjects
RecruitingPhase 1
Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RecruitingObservational study
Urinary Vitamin C Loss in Diabetic Subjects
Diabetes
Active, not recruitingPhase 1/2
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Hypothalamic Obesity, Prader-Willi Syndrome
Recruiting
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
Aging, Frailty
Active, not recruitingPhase 1
To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Healthy Volunteers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing Assistive Pulse Data Collection (APDC) Device in people with Healthy Male and Female Subjects, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rating on the Agreement in pulse feature (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06974227, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.